Ares Capital's Non-Accruals Rose to 2.4% of Its Portfolio, Still Below Its Own Historical Average

Ares Capital reported non-accrual loans rising to 2.4% of the portfolio in Q2 2026 from 1.8% a year earlier (+60 bps), a negative direction for loan quality. The level remains modest versus Ares’ ~3% Great Recession-era historical average and the industry’s ~4% average, suggesting the issue may reflect mean reversion rather than a deterioration. With clients paying an average 10.3% interest rate and the company targeting a ~9.5% yield, investors should monitor whether non-accruals move toward 3% or continue rising.

Analysis

The market implication is less about a single uptick in troubled loans and more about where we are in the credit cycle: BDCs are now being paid to absorb refinancing risk from small-cap borrowers whose access to cheap capital has tightened. That is constructive for higher-quality lenders with stronger underwriting, but it compresses the gap between “performing” and “problematic” quickly once defaults start migrating from idiosyncratic names into a sector-wide pattern. ARCC is still in the better half of the pack, but the first-order protection is already in the price; incremental downside would likely come from spread widening and NAV marks before headline non-accruals look alarming.

The second-order issue is dividend durability. For BDCs, the equity story is really a balance-sheet story disguised as yield: if non-accruals keep creeping, the combined hit from lost interest income and lower recoveries can pressure spillover earnings and force a slower pace of special distributions or buybacks. That risk is not immediate, but it becomes relevant over the next 1-3 quarters if floating-rate borrowers face softer earnings and a still-high cost of debt. The key watch item is not the non-accrual percentage alone, but whether new problem loans are concentrated in cyclical sectors that tend to deteriorate in clusters.

Contrarian view: consensus may be too complacent because “still below historical average” is backward-looking when private credit underwriting standards have been loosening broadly. The overhang is not a near-term dividend cut; it is multiple compression if investors start pricing BDCs like levered credit vehicles rather than bond proxies. Falsifiers would be stabilization in non-accruals, flat-to-up NAV per share, and continued dividend coverage into the next earnings cycle; if non-accruals move above 3% and stay there, the case shifts from monitor to reduce.

Key Decisions for Investors

• Avoid initiating fresh longs in ARCC until the next earnings print confirms non-accruals have stabilized and NAV per share is flat-to-up; the current setup offers limited upside with asymmetric credit-cycle risk over 1-3 quarters.
• Relative-value: favor higher-quality BDCs with cleaner credit metrics over ARCC; if you need BDC exposure, prefer the names with lower non-accrual drift and stronger dividend coverage rather than the highest headline yield.
• Set an alert on ARCC if non-accruals approach 3.0% or if management signals weaker spillover income; that is the point where dividend sustainability and multiple compression become investable risks, not just accounting noise.
• For a cautious hedge, consider a short ARCC vs. long a lower-leverage credit proxy or a better-underwritten BDC basket if spread volatility picks up; this is a relative quality trade, not a directional macro short.